ID   MY-M13
AC   CVCL_3036
SY   MY clone M13
DR   CLO; CLO_0037186
DR   JCRB; JCRB0158.2
DR   JCRB; NIHS0246.2
DR   LINCS_LDP; LCL-1003
DR   Wikidata; Q54907143
RX   PubMed=9790503;
CC   Population: Japanese.
CC   Discontinued: JCRB; NIHS0246.2; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Mononuclear cell; CL=CL_0000842.
ST   Source(s): JCRB=JCRB0158.2
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 8
ST   D16S539: 9
ST   D5S818: 11,13
ST   D7S820: 10,13
ST   TH01: 9
ST   TPOX: 8,11
ST   vWA: 17,18
DI   NCIt; C4673; Acute biphenotypic leukemia
DI   ORDO; Orphanet_530995; Mixed phenotype acute leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_3034 ! MY
SX   Female
AG   52Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 20
//
RX   PubMed=9790503; DOI=10.1002/(SICI)1098-2264(199811)23:3<227::AID-GCC4>3.0.CO;2-3;
RA   Inokuchi K., Shinohara T., Futaki M., Hanawa H., Tanosaki S.,
RA   Yamaguchi H., Nomura T., Dan K.;
RT   "Establishment of a cell line with variant BCR/ABL breakpoint
RT   expressing P180BCR/ABL from late-appearing Philadelphia-positive acute
RT   biphenotypic leukemia.";
RL   Genes Chromosomes Cancer 23:227-238(1998).
//